Advances in Reproductive Medicine: State of the Art in Diagnosis and Emerging Perspectives

Dear Colleagues,

(1) Introduction

Reproductive medicine has undergone remarkable transformation in recent years, driven by advances in diagnostic technologies that are reshaping how clinicians assess and manage conditions across reproductive endocrinology, embryology, infertility, fertility preservation, and oncofertility. As diagnostic tools grow more precise, accessible, and integrated into clinical workflows, they are enabling earlier detection, more personalized treatment planning, and improved outcomes for patients navigating complex reproductive health challenges. Despite this progress, significant diagnostic challenges remain, particularly in translating novel technologies into standardized, evidence-based clinical practice. We are pleased to invite you to contribute to this Special Issue, which brings together current research and perspectives on diagnostic innovation across the reproductive medicine field.

(2) Aim of the Special Issue

This Special Issue aims to provide a comprehensive, state-of-the-art overview of diagnostic advances in reproductive medicine, spanning reproductive endocrinology, embryology, infertility, fertility preservation, and oncofertility. By uniting basic science, translational research, and clinical perspectives, this Special Issue seeks to highlight how emerging diagnostic methods and technologies are shaping patient care, informing treatment decisions, and addressing unmet needs across the reproductive health spectrum.

(3) Suggested Themes and Article Types for Submissions

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• Novel diagnostic methods and biomarkers in reproductive medicine;
• Advances in embryo assessment, selection, and evaluation technologies;
• Diagnostic approaches to infertility evaluation and management;
• Innovations in fertility preservation and patient assessment;
• Diagnostic and monitoring considerations in oncofertility care;
• Integration of AI, imaging, and molecular diagnostics into reproductive medicine;
• Emerging technologies and methodological advances in reproductive medicine;
• Clinical and translational perspectives on improving diagnostic accuracy and patient outcomes.

We look forward to receiving your contributions.

Dr. Diego Manavella
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.